Clinical Trial

NT-NOA - Novel Treatment of Some Men With Non-Obstructive Azoospermia

Study acronym: NT-NOA
Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This clinical interventional study aims to assess whether treatment with denosumab in combination with letrozole can improve sperm production in infertile men with non-obstructive azoospermia selected by serum anti-mullerian hormone (AMH) as a positive predictive biomarker.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-11-22; most recent amendment 2026-04-16.
Status change: Recruiting → Active, Not Recruiting 2025-11-28
Status change: Active, Not Recruiting → Recruiting 2025-04-01
Trial Details
NCT Number NCT06706414
Lead Sponsor Martin Blomberg Jensen
Conditions Infertility, Male
Enrollment 16 participants
Start Date 2025-03-01
Primary Completion 2026-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2026-04-17